Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR7280 in Menorrhagia Associated with Uterine Fibroids
NCT05442827Phase 3Recruiting
- Sponsor
- Hengrui
- Start
- Sep 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SHR7280 in uterine leiomyoma, Menorrhagia, sponsored by Hengrui. Started Sep 2022; status: recruiting.
02
Drugs
SHR7280
03
Conditions
uterine leiomyomaMenorrhagia
Beyond the preview
Go deeper on NCT05442827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05442827.